首页> 美国卫生研究院文献>PLoS Clinical Trials >Development and Validation of Burkholderia pseudomallei-Specific Real-Time PCR Assays for Clinical, Environmental or Forensic Detection Applications
【2h】

Development and Validation of Burkholderia pseudomallei-Specific Real-Time PCR Assays for Clinical, Environmental or Forensic Detection Applications

机译:用于临床,环境或法医检测应用的伯克霍尔德氏菌假性马来特异性实时PCR分析方法的开发和验证

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The bacterium Burkholderia pseudomallei causes melioidosis, a rare but serious illness that can be fatal if untreated or misdiagnosed. Species-specific PCR assays provide a technically simple method for differentiating B. pseudomallei from near-neighbor species. However, substantial genetic diversity and high levels of recombination within this species reduce the likelihood that molecular signatures will differentiate all B. pseudomallei from other Burkholderiaceae. Currently available molecular assays for B. pseudomallei detection lack rigorous validation across large in silico datasets and isolate collections to test for specificity, and none have been subjected to stringent quality control criteria (accuracy, precision, selectivity, limit of quantitation (LoQ), limit of detection (LoD), linearity, ruggedness and robustness) to determine their suitability for environmental, clinical or forensic investigations. In this study, we developed two novel B. pseudomallei specific assays, 122018 and 266152, using a dual-probe approach to differentiate B. pseudomallei from B. thailandensis, B. oklahomensis and B. thailandensis-like species; other species failed to amplify. Species specificity was validated across a large DNA panel (>2,300 samples) comprising Burkholderia spp. and non-Burkholderia bacterial and fungal species of clinical and environmental relevance. Comparison of assay specificity to two previously published B. pseudomallei-specific assays, BurkDiff and TTS1, demonstrated comparable performance of all assays, providing between 99.7 and 100% specificity against our isolate panel. Last, we subjected 122018 and 266152 to rigorous quality control analyses, thus providing quantitative limits of assay performance. Using B. pseudomallei as a model, our study provides a framework for comprehensive quantitative validation of molecular assays and provides additional, highly validated B. pseudomallei assays for the scientific research community.
机译:假苹果伯克霍尔德氏菌会引起类鼻oid病,这是一种罕见但严重的疾病,如果不及时治疗或误诊可能会致命。物种特异性PCR分析提供了一种技术上简单的方法,可将假苹果芽孢杆菌与近邻物种区分开。然而,该物种内大量的遗传多样性和高水平的重组降低了分子标记将所有假芽孢杆菌与其他伯克霍尔德氏菌区分开的可能性。当前可用的用于假性麦芽孢杆菌检测的分子分析方法在大型计算机数据集中缺乏严格的验证,并无法通过分离物收集来测试特异性,并且都没有严格的质量控制标准(准确性,精密度,选择性,定量限(LoQ),极限检测(LoD),线性,坚固性和耐用性),以确定它们是否适合环境,临床或法医研究。在这项研究中,我们开发了两种新颖的假疟原虫特异性检测方法,分别为122018和266152,使用双探针方法将假疟原虫与泰国芽孢杆菌,俄克拉荷马芽孢杆菌和泰国芽孢杆菌样物种区分开来。其他物种未能扩增。在包括伯克霍尔德氏菌(Burkholderia spp)的大型DNA面板(> 2,300个样品)中验证了物种特异性。与非伯克霍尔德菌的细菌和真菌物种具有临床和环境相关性。与之前发布的两种假苹果芽孢杆菌特异性测定法BurkDiff和TTS1的测定特异性比较,证明了所有测定法的可比性,对我们分离株的特异性为99.7至100%。最后,我们对122018和266152进行了严格的质量控制分析,从而提供了定量的测定性能极限。以假单胞菌为模型,我们的研究为分子测定的全面定量验证提供了框架,并为科研界提供了额外的,经过高度验证的假单胞菌测定。

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号